Form 4 for IRMD IRADIMED CORP
Accepted 2021-11-24 00:00:00 ET · period of report 2021-11-23 · accession 0000898432-21-000740 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-24 | 2021-11-23+ | IRMD | HAWKINS JAMES B | Dir | S - Sale | $42.71 | -43.5K | 17.3K | -72% | -$1.86M |
| DM | 2021-11-24 | 2021-11-23+ | IRMD | HAWKINS JAMES B | Dir | A - Grant | $1.48 | +43.5K | 23.3K | New | +$64.4K |
| DM | 2021-11-24 | 2021-11-23+ | IRMD | HAWKINS JAMES B | Dir | M - OptEx | $0.00 | -43.5K | 84.0K | -34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-24 | S | D | 37,454 | $42.95 | 17,268 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $42.25 to $44.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2021-11-24 | A | A | 37,454 | $1.48 | 54,722 | D | — | — | (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |
| 3 | Common | Common Stock | 2021-11-23 | S | D | 6,038 | $41.20 | 17,268 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $41.20 to $41.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2021-11-23 | A | A | 6,038 | $1.48 | 23,306 | D | — | — | (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |
| 5 | Derivative | Stock Options (Right to Buy) | 2021-11-24 | M | D | 37,454 | $0.00 | 46,508 | D | $1.48 · — to 2023-12-31 | 37,454 Common Stock | (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |
| 6 | Derivative | Stock Options (Right to Buy) | 2021-11-23 | M | D | 6,038 | $0.00 | 83,962 | D | $1.48 · — to 2023-12-31 | 6,038 Common Stock | (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |